Business Context and Reporting Period
Company: IRADIMED CORP (IRMD)
Filing Type: Form 8-K (Current Report)
Report Date: October 29, 2021
Reporting Period: Third quarter ended September 30, 2021
This filing serves as a notification that the company issued a press release announcing its financial results for the third quarter of 2021. The detailed financial data is contained in the press release furnished as Exhibit 99.1, which is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the attached press release (Exhibit 99.1) but are not present in the body of this Form 8-K summary.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. It only confirms the issuance of results for the third quarter ended September 30, 2021.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release containing the results but does not include the text of the commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Unusual Items: None reported in the text of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 29, 2021) for actual revenue, net income, and EPS figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any forward-looking guidance or updated full-year projections in the press release.
- Confirm the company's status as an emerging growth company (indicated as checked in the filing).